Helsinn Supports the Development of NCCN Guidelines for Patients® on Nausea and Vomiting, with a Sponsorship Grant
Lugano, Switzerland, April 11, 2016: Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, announces that it is supporting…